top of page
The Professional Network for Healthcare Experts
GE HealthCare agrees $945m acquisition of SOFIE Biosciences to expand US radiopharma network
GE HealthCare has agreed to acquire SOFIE Biosciences for $945 million, expanding its US PET radiopharmaceutical manufacturing and distribution network.
nuaxia
Oct 62 min read
Novartis licenses BoomRay radioligand therapy in deal worth up to $900m
Novartis has secured exclusive worldwide rights to an undisclosed preclinical radioligand therapy from BoomRay Pharma in a licensing agreement worth up to $900 million.
nuaxia
Sep 232 min read
Telix and ITM agree $1.65bn radiopharmaceutical merger
Telix Pharmaceuticals has agreed to acquire ITM in a major radiopharmaceutical transaction valued at $1.65 billion upfront, with up to a further $700 million linked to regulatory and commercial milestones.
nuaxia
Sep 212 min read
Sanofi and Lilly Back AdvanCell’s $315M Radiopharmaceutical Expansion as ADVC001 Moves Towards Late-Stage Development
Funding round will support development of lead targeted alpha therapy ADVC001 in metastatic prostate cancer and expand Lead-212 manufacturing capabilities.
nuaxia
Jul 173 min read
bottom of page